Microsoft yesterday announced another customer win in the enterprise for Windows 8.1 tablets. PHT Corporation, the leading provider of technologies used to collect patient-driven electronic data for clinical research, has selected Dell Venue 11 Pro tablets featuring Windows 8.1 to run its SitePad® System. PHT will deploy more than 2,000 Dell Venue 11 Pros that will be deployed at clinical trial sites around the globe.
PHT selected the Dell Venue 11 Pro with Windows 8.1 for the SitePad platform because the device provides a superior user experience. The Venue has a high-resolution touch screen that supports greater ease of use for both clinicians and patients. In addition to providing a superior user experience, the Dell Venue provides multiple modes of data communications including Wi-Fi, Ethernet and an embedded 4G card.
PHT chose the Windows 8.1 tablets because of the flexibility and security aspects of Microsoft technology and because the solution allows PHT to increase the quality of real-time site-based data capture for trial participants and clinicians. It also allows PHT to run custom software that helps decrease clinical trial costs for sponsors by reducing time spent downstream resolving missing and inconsistent data. The superior end-user experience helps provide additional convenience and comfort for end users, enabling rapid entry of electronic source clinical data.
Sheila Rocchio, vice president of Marketing & Product Management at PHT commented the following on choosing Dell Venue 11 Pro,
“The Dell Venue 11 Pro with Windows 8.1 is a modern and sleek device that both patients and clinicians enjoy using — the usability testing feedback has been excellent,” Rocchio said. “Sponsors are also very excited about the embedded 4G modem in the Dell Venue 11 Pro, which eliminates the need for an additional wireless hotspot, making setup much easier.”